JAJhancy Rocio Aguilar-Jimenez

Jhancy Rocio Aguilar-Jimenez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jhancy Rocio Aguilar-Jimenez has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Reliability and validity of the Perceived Stress Scale among Colombian university students in the health sciences

    by Martha J. Rodríguez, Yeny Z. Castellanos-Domínguez, Sahira G. Franco-Hernández, Jhancy R. Aguilar-Jimenez, Paula C. Ramirez

  • Open Access

    High prevalence of antibiotic purchase without prescription in community pharmacies in Bucaramanga, Colombia

    by Juan Camilo Caamaño-López, Rafael José Torres-Chaverra, Aylem Nathalia Fonseca-Meneses, Eliat Jabit Pérez-Cujia, Valentina Domínguez-Quintero, Heyleen Yuliana Ortiz-Centeno, Luisa Fernanda Jiménez-Vásquez, Andrés Felipe Trujillo-Mejía, Cristina Isabel Amado-Cabrales, Linda Vanessa Osorio-Cardozo, et al.

  • Factors associated with disease severity in hospitalized children with Staphylococcus aureus infection

    by Karen Linceyth Becerra Riaño, José Antonio Vargas Soler, Jhancy Rocío Aguilar-Jimenez

    Staphylococcus aureus is a common cause of serious infections in children, with the incidence of methicillin-resistant Staphylococcus aureus (MRSA) rising in recent decades. To identify the factors associated with disease severity in pediatric patients hospitalized with S. aureus infection in high-complexity institutions in Santander, Colombia. A cross-sectional study was conducted among children under 18 years of age with S. aureus infection who were hospitalized (2018–21). Clinical characteristics and outcomes were compared between MRSA and methicillin-susceptible Staphylococcus aureus (MSSA) infections. Factors associated with severity were identified through multivariate analysis with logistic and binomial regression. One hundred fifty-four cases of S. aureus infection were included, with 75 (48.7%) being MRSA. Among community-acquired infections, 55.7% (44/79) were caused by MRSA. Pediatric intensive care unit (PICU) admission was required in 55.8% of cases, and the infection-attributable case-fatality rate (CFR) was 1.9%. MRSA infections were associated with a greater need for vasopressor/inotropic support (prevalence ratio [PR], 2.06; 95% confidence interval [CI], 1.05–4.04; P = .036). Persistent bacteremia was associated with an increased PICU admission (PR 1.72; 95%CI: 1.19–2.46), mechanical ventilation (PR 8.63; 95%CI: 3.16–23.54), and vasopressor/inotropic support (PR 11.06; 95%CI: 4.59–26.58). S. aureus infections showed a high prevalence of MRSA, with a notable proportion of community-acquired cases. More than half required admission to PICU, but the infection-attributable CFR was low. MRSA infections and persistent bacteremia were associated with disease severity. These findings support the use of timely antibiotic therapy and reinforce the need for infection prevention and control strategies.


  • Top Cited Papers
    Open Access

    Perceived stress, coping strategies and associated factors among Colombian undergraduate health science students

    by Martha J. Rodríguez, Yeny Z. Castellanos-Domínguez, Jhancy R. Aguilar-Jimenez, Sahira G. Franco-Hernández, Tito C. Quintero-Gómez, Paula C. Ramírez

    Students involved in health sciences programs usually experience high levels of stress due to the academic loads, clinical responsibilities, and emotional


  • Open Access

    Correcting drug-resistance prevalence in tuberculosis using a predictive model of diagnostic access

    by Jhancy Rocio Aguilar-Jimenez, Fredi Alexander Diaz-Quijano

    Background: Drug resistance (DR) poses a major challenge to tuberculosis (TB) elimination. Incomplete access to diagnostic tests can lead to under detection and biased DR-TB prevalence indicators. This study aimed to estimate the prevalence of DR-TB, identified through any available diagnostic method, while correcting for disparities in access to rapid molecular testing ( Xpert ® MTB/RIF ), used as a proxy for overall diagnostic capacity. Methods: We conducted a cross-sectional study of new TB cases in individuals aged over 18 (n=406,331), using 2015-2020 data from the Brazilian Information System on Notifiable Diseases (SINAN). We assumed that access to Xpert ® MTB/RIF was an indicator of better diagnostic conditions for detecting drug resistance in general, because patients who underwent this test had a higher prevalence of all forms of resistance (not just to rifampicin). We developed a multilevel mixed-effects logistic regression model, incorporating individual- and municipality-level variables, to predict access to Xpert ® MTB/RIF testing in a random sample of 81,027 observations. The model was validated using out-of-sample observations across geographic areas. We then used inverse probability weighting based on predicted access to calculate corrected estimates of DR-TB prevalence. Results: The model showed good performance (AUC=80·93%, 95%CI: 80·71%-81·33%). The prevalence of DR-TB reported by the surveillance system was 1·54% (95%CI: 1·50%-1·57%). Among patients tested with Xpert ® MTB/RIF , DR-TB prevalence was 3·86% (95%CI: 3·75%-3·96%), and the corrected weighted prevalence was 5·95% (95%CI: 5·54%-6·38%). Conclusions: The prevalence of DR-TB may be substantially underestimated due to uneven access to testing. Our approach highlights the importance of correcting for diagnostic access to improve surveillance indicators.

  • How has the municipal availability of the GeneXpert®MTB/RIF system affected the detection of drug‐resistant tuberculosis in Brazil?

    by Jhancy Rocío Aguilar‐Jiménez, Daniele Maria Pelissari, Fredi Alexander Diaz‐Quijano

    Objective: To evaluate the association between the availability of GeneXpert®MTB/RIF in municipalities and the proportion of people who have access to this diagnostic technology for tuberculosis (TB), as well as the resistance detected by the surveillance system in Brazil.Methods: We analysed 4998 Brazilian municipalities that reported 432,937 new TB cases between 2015 and 2020. We compared municipalities with and without the availability of GeneXpert®MTB/RIF regarding the effective access to GeneXpert®MTB/RIF diagnosis and the prevalence of detected resistance.Results: Municipalities with at least one GeneXpert®MTB/RIF system had three times (95% CI 2.9–3.0) the access to diagnostic tests and 80.4% (95% CI 70.6%–90.2%) higher detection of resistance, compared with municipalities without this technology. We estimated that there have been 1890 cases of undetected resistance during this period in the country.Conclusions: The availability of GeneXpert®MTB/RIF system in the municipality increased the sensitivity of the surveillance for detecting TB resistance.Public Health Implications: It is a priority to strengthen laboratory networks and narrow the gap in access to rapid diagnosis in remote areas to improve the detection and control of drug‐resistant tuberculosis.


  • Open Access

    How has the municipal availability of the GeneXpert ® MTB/RIF system affected the detection of drug-resistant tuberculosis in Brazil?

    by Jhancy Rocío Aguilar-Jiménez, Daniele Maria Pelissari, Fredi Alexander Diaz-Quijano

    Objective: To evaluate the association between the availability of GeneXpert ® MTB/RIF in municipalities and the proportion of people who have access to this diagnostic technology for tuberculosis (TB), as well as the resistance detected by the surveillance system in Brazil. Methods: We analyzed 4,998 Brazilian municipalities that reported 432,937 new TB cases between 2015 and 2020. We compared municipalities with and without the availability of GeneXpert ® MTB/RIF regarding the prevalence of effective access to GeneXpert ® MTB/RIF diagnosis and that of detected resistance. Results: Municipalities with at least one GeneXpert ® MTB/RIF system had three times (95%CI 2.9-3.0) the access to diagnostic tests and 80.4% (95%CI 70.6%-90.2%) higher detection of resistance, compared to municipalities without this technology. We estimate that there have been 2,110 cases of undetected resistance during this period in the country. Conclusions: The availability of GeneXpert ® MTB/RIF system in the municipality increased the sensitivity of the surveillance for detecting TB resistance. Public Health implications: It is a priority to strengthen laboratory networks and narrow the gap in access to rapid diagnosis in remote areas to improve the detection and control of drug-resistant tuberculosis.

  • Información y datos abiertos en tiempos de desigualdades en salud

    by Jhacy Rocío Aguilar-Jiménez, Sergio Mauricio Moreno López, Lina Zapata Vélez

    El conocimiento, la ciencia y la información tienen una relación de interdependencia. Como su convergencia no cesa de producir cambios sustanciales en la historia de la humanidad, es de esperarse que la manera de concebirlos nunca haya sido estática. Por su parte, estas concepciones, que son fenómenos vivos, dinámicos e intangibles, erigen nuevas formas de ver y habitar el mundo. La información es un concepto revolucionario porque: primero, encierra los conceptos de masa y energía; segundo, tiene la capacidad para controlar diversas facetas de la humanidad, tales como: las elecciones, las decisiones de los consumidores, la balanza del mercado, etc. En la actualidad, el mundo está invadido por un enorme volumen de datos, que no deja de aumentar de manera exponencial todos los días y, por esto, es menesteroso que los usuarios desarrollen un pensamiento crítico en lo tocante con su tratamiento, su uso y el grado de representatividad que puede llegar a tener en distintos ámbitos.